Advertisement

News Stories

Jun, 2018

0
No votes yet
Name: NLA News
May, 2018


SILVER SPRING, Md. – National Lipid Association Board Member Lori Alexander, MSHS, RD, CCRC, CLS, FNLA testified on Thursday, May 10 in front of the Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee on behalf of familial chylomicronemia patients. The committee held a hearing regarding the safety and efficacy of a new treatment for FCS, volanesorsen.

0
No votes yet
Name: NLA News
Apr, 2018

Chicago-area cardiologist assumes role during NLA Scientific Sessions in Las Vegas

0
No votes yet
Name: NLA News

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service